Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Sanna Bastiano | EVP, Cell & Genetic Therapies | May 04 | Sale | 275.09 | 36 | 9,903 | 41,660 | May 06 04:05 PM | Arbuckle Stuart A | EVP, COO | May 02 | Sale | 263.98 | 306 | 80,778 | 64,760 | May 04 05:21 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | May 02 | Sale | 259.16 | 320 | 82,930 | 41,696 | May 04 05:10 PM | Bhatia Sangeeta N. | Director | May 02 | Sale | 258.94 | 737 | 190,842 | 5,903 | May 04 05:09 PM | WAGNER CHARLES F JR | EVP & Chief Financial Officer | May 02 | Sale | 258.83 | 343 | 88,778 | 42,730 | May 04 05:07 PM | Liu Joy | SVP, General Counsel | Apr 29 | Sale | 275.41 | 120 | 33,049 | 14,334 | May 03 04:28 PM | Ambrose Kristen | SVP & Chief Accounting Officer | Apr 25 | Sale | 269.55 | 327 | 88,143 | 3,496 | Apr 27 04:05 PM | Lee Yuchun | Director | Apr 18 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 20 04:05 PM | Lee Yuchun | Director | Apr 18 | Sale | 284.23 | 2,000 | 568,467 | 1,875 | Apr 20 04:05 PM | Lee Yuchun | Director | Apr 14 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 18 04:05 PM | Lee Yuchun | Director | Apr 14 | Sale | 289.06 | 2,000 | 578,117 | 1,875 | Apr 18 04:05 PM | Lee Yuchun | Director | Apr 13 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 14 04:35 PM | Lee Yuchun | Director | Apr 13 | Sale | 287.50 | 2,000 | 575,010 | 1,875 | Apr 14 04:35 PM | LEIDEN JEFFREY M | Executive Chairman | Apr 13 | Sale | 289.04 | 15,789 | 4,563,653 | 74,160 | Apr 14 04:35 PM | Lee Yuchun | Director | Apr 12 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 14 04:35 PM | Lee Yuchun | Director | Apr 12 | Sale | 281.03 | 2,000 | 562,051 | 1,875 | Apr 14 04:35 PM | Lee Yuchun | Director | Apr 11 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 12 04:07 PM | Lee Yuchun | Director | Apr 11 | Sale | 280.30 | 2,000 | 560,599 | 1,875 | Apr 12 04:07 PM | MCGLYNN MARGARET G | Director | Apr 08 | Option Exercise | 127.54 | 5,000 | 637,700 | 6,099 | Apr 12 04:05 PM | Bhatia Sangeeta N. | Director | Apr 08 | Option Exercise | 125.71 | 1,907 | 239,729 | 7,098 | Apr 12 04:05 PM | Lee Yuchun | Director | Apr 08 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 12 04:07 PM | Lee Yuchun | Director | Apr 08 | Sale | 278.57 | 2,000 | 557,141 | 1,875 | Apr 12 04:07 PM | Bhatia Sangeeta N. | Director | Apr 08 | Sale | 280.20 | 1,907 | 534,341 | 5,191 | Apr 12 04:05 PM | MCGLYNN MARGARET G | Director | Apr 08 | Sale | 280.22 | 5,000 | 1,401,080 | 1,099 | Apr 12 04:05 PM | Lee Yuchun | Director | Apr 07 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 08 05:57 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | Apr 07 | Sale | 276.18 | 561 | 154,935 | 42,782 | Apr 08 04:34 PM | Lee Yuchun | Director | Apr 07 | Sale | 274.86 | 2,000 | 549,720 | 1,875 | Apr 08 05:57 PM | Lee Yuchun | Director | Apr 06 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 08 05:57 PM | Lee Yuchun | Director | Apr 06 | Sale | 271.62 | 2,000 | 543,243 | 1,875 | Apr 08 05:57 PM | Lee Yuchun | Director | Apr 05 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 06 04:59 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | Apr 05 | Sale | 275.23 | 3,163 | 870,552 | 43,343 | Apr 06 05:02 PM | Lee Yuchun | Director | Apr 05 | Sale | 272.50 | 2,000 | 544,993 | 1,875 | Apr 06 04:59 PM | Lee Yuchun | Director | Apr 04 | Option Exercise | 81.54 | 2,000 | 163,080 | 3,875 | Apr 06 04:59 PM | Lee Yuchun | Director | Apr 04 | Sale | 267.72 | 2,000 | 535,431 | 1,875 | Apr 06 04:59 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | Apr 04 | Sale | 267.71 | 562 | 150,452 | 46,506 | Apr 06 05:02 PM | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Apr 01 | Sale | 264.76 | 2,582 | 683,602 | 43,620 | Apr 05 04:06 PM | MCGLYNN MARGARET G | Director | Mar 31 | Option Exercise | 127.54 | 5,000 | 637,700 | 6,099 | Apr 04 04:05 PM | MCGLYNN MARGARET G | Director | Mar 31 | Sale | 262.27 | 5,000 | 1,311,346 | 1,099 | Apr 04 04:05 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Mar 17 | Sale | 250.11 | 2,833 | 708,572 | 47,356 | Mar 21 04:15 PM | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Mar 17 | Sale | 250.15 | 3,171 | 793,218 | 46,202 | Mar 21 04:12 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | Mar 17 | Sale | 250.06 | 2,122 | 530,627 | 48,412 | Mar 21 04:10 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 25 | Sale | 230.95 | 325 | 75,058 | 50,189 | Feb 28 05:27 PM | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 18 | Sale | 231.00 | 519 | 119,889 | 53,104 | Feb 22 05:03 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 18 | Sale | 230.97 | 4,312 | 995,949 | 49,687 | Feb 22 04:51 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 14 | Sale | 232.02 | 2,444 | 567,057 | 57,438 | Feb 16 04:05 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 11 | Sale | 235.02 | 2,297 | 539,837 | 59,882 | Feb 14 04:11 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 02 | Option Exercise | 86.52 | 4,660 | 403,183 | 70,357 | Feb 03 04:06 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 02 | Sale | 251.47 | 4,660 | 1,171,842 | 65,697 | Feb 03 04:06 PM | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Feb 02 | Sale | 250.07 | 2,944 | 736,206 | 57,435 | Feb 03 04:29 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | Feb 02 | Sale | 250.98 | 1,040 | 261,017 | 54,952 | Feb 03 04:26 PM | MCGLYNN MARGARET G | Director | Jan 28 | Option Exercise | 127.54 | 5,000 | 637,700 | 6,099 | Feb 01 04:09 PM | MCGLYNN MARGARET G | Director | Jan 28 | Sale | 241.79 | 5,000 | 1,208,960 | 1,099 | Feb 01 04:09 PM | Sachdev Amit | EVP, Chief Patient Officer | Nov 15 | Sale | 187.19 | 51 | 9,547 | 31,928 | Nov 16 04:07 PM | Arbuckle Stuart A | EVP, COO | Nov 15 | Sale | 187.26 | 3 | 562 | 41,103 | Nov 16 04:05 PM | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15 | Sale | 187.22 | 34 | 6,365 | 33,589 | Nov 16 04:04 PM | Kewalramani Reshma | CEO & President | Aug 19 | Buy | 195.65 | 10,000 | 1,956,492 | 73,754 | Aug 23 08:30 AM | SACHS BRUCE I | Director | Aug 02 | Buy | 197.91 | 15,000 | 2,968,650 | 41,210 | Aug 04 04:05 PM | Bhatia Sangeeta N. | Director | Jun 02 | Sale | 209.69 | 559 | 117,216 | 5,191 | Jun 04 04:03 PM | Arbuckle Stuart A | EVP, Chief Comm & Ops Officer | May 17 | Sale | 216.41 | 109 | 23,589 | 41,103 | May 19 04:04 PM | ALTSHULER DAVID | EVP, Global Research and CSO | May 17 | Sale | 216.36 | 79 | 17,093 | 33,589 | May 19 04:02 PM | Sanna Bastiano | EVP, Cell & Genetic Therapies | May 17 | Sale | 216.34 | 112 | 24,230 | 34,108 | May 19 04:10 PM | Sachdev Amit | EVP, Chief Patient Officer | May 17 | Sale | 216.35 | 45 | 9,736 | 40,133 | May 19 04:08 PM |
|